Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (271-280 of 868) with videos related to

Pageof 87
Sort By:
Biochemical and Biophysical Research Communications|March 17, 2004
TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytesMasaharu Akiyama, Osamu Yamada, Teru Hideshima, et al.
Cancer Discovery|June 18, 2015
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive MyelomaFrancesca Cottini, Teru Hideshima, Rikio Suzuki, et al.
Blood Advances|April 6, 2023
A pandemic preparedness network for individuals living with compromised immune systemsWilliam A Wood, Kenneth C Anderson, Shaji K Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Targeting the phosphatidylinositol 3-kinase pathway in multiple myelomaHashem Younes, Xavier Leleu, Evdoxia Hatjiharissi, et al.
Experimental Hematology|April 15, 2003
Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cellsStephanie Greenstein, Nancy L Krett, Yoshihiro Kurosawa, et al.
Blood Advances|October 14, 2021
Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survivalTianzeng Chen, Matthew Ho, Jenna Briere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myelomaMasood A Shammas, Robert J Shmookler Reis, Cheng Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2025
Editor's Note: Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma CellsDeepika Sharma Das, Abhishek Das, Arghya Ray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2017
Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma CellsDeepika Sharma Das, Abhishek Das, Arghya Ray, et al.
Clinical Advances in Hematology & Oncology : H&O|August 28, 2018
The evolving role of transplantation in multiple myeloma: the need for a heterogeneous approach to a heterogeneous diseaseSara Gandolfi, Carolyn Vekstein, Jacob P Laubach, et al.
Pageof 87

Showing results (271-280 of 868) with videos related to

Sort By:
Pageof 87
Biochemical and Biophysical Research Communications|March 17, 2004
TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytesMasaharu Akiyama, Osamu Yamada, Teru Hideshima, et al.
Cancer Discovery|June 18, 2015
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive MyelomaFrancesca Cottini, Teru Hideshima, Rikio Suzuki, et al.
Blood Advances|April 6, 2023
A pandemic preparedness network for individuals living with compromised immune systemsWilliam A Wood, Kenneth C Anderson, Shaji K Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Targeting the phosphatidylinositol 3-kinase pathway in multiple myelomaHashem Younes, Xavier Leleu, Evdoxia Hatjiharissi, et al.
Experimental Hematology|April 15, 2003
Characterization of the MM.1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cellsStephanie Greenstein, Nancy L Krett, Yoshihiro Kurosawa, et al.
Blood Advances|October 14, 2021
Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survivalTianzeng Chen, Matthew Ho, Jenna Briere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myelomaMasood A Shammas, Robert J Shmookler Reis, Cheng Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2025
Editor's Note: Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma CellsDeepika Sharma Das, Abhishek Das, Arghya Ray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2017
Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma CellsDeepika Sharma Das, Abhishek Das, Arghya Ray, et al.
Clinical Advances in Hematology & Oncology : H&O|August 28, 2018
The evolving role of transplantation in multiple myeloma: the need for a heterogeneous approach to a heterogeneous diseaseSara Gandolfi, Carolyn Vekstein, Jacob P Laubach, et al.
Pageof 87